Colon-cancer drug success
4th Nov 2005, 12:59 GMT
Southern California biotech giant Amgen and small biotech Abgenix of Fremont announced Thursday that their colon cancer drug panitumumab slowed tumor growth, almost cutting in half the chance the cancer would worsen.
Colon-cancer drug success related news:
- Expanded use sought for colon cancer drug — News-Medical News Feed
- Chemo Drug May Up Pancreatic Cancer Survival — WebMD Health Headlines
- Experimental cancer drug results sends biotech companies' stocks soaring — SacBee -- Business
- Diabetics at higher risk of colon cancer (Reuters) — Yahoo! News: Health News
- Diabetes Raises Colon Cancer Risk — MedicineNet Cancer General
- Young Blacks at Higher Colon Cancer Risk (HealthDay) —
- Diabetics at higher risk of colon cancer — Reuters: Health
- Women More Prone to Tobacco-Linked Colon Cancer — MedicineNet Cancer General
- Young Blacks at Higher Colon Cancer Risk — Rednova News - Health
- FDA Expedites Review of Erbitux for Head, Neck Cancers — KeralaNext: International
Latest news from RSS Top Stories -- SiliconValley.com:
- Valley apartment rents likely to keep rising
- Tech companies push for lame-duck action on R&D tax credit
- Traffic to online gambling sites drops in wake of new U.S. law
- Major Vonage holders holding off on step that would free them to sell shares
- Gates: Vista launch could be biggest since Windows 95
- Motorola to buy Netopia for $208 million in cash
- U.S. online advertising increases again in Q3
- First take on Zune: In a couple more versions, Microsoft may have something
- Projects aimed at solving global problems get honors
- Would-be PS3 buyers waiting it out